A phase II trial of high dose epirubicin in patients with advanced breast carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/10640971

Cancer 2000 Jan 15 88 2 375-80

Download in:

View as

Triples

General Info

PMID
10640971